ÂÜÀòÂÒÂ×

Beth Griffith is a scientist at SBH Sciences since November 2020, specializing in optimizing assays for point-of-care biosensors and supporting type 2 diabetes gene therapy research through various techniques including construct screening and preclinical studies. Prior to this role, Beth served as a technical writer, focusing on grant writing for federal submissions. Academic experience includes postdoctoral positions at Yale University and Stanford University, as well as a graduate research and teaching assistantship at Yale University. Educational qualifications comprise a PhD in Molecular Cellular and Developmental Biology from Yale University, a Professional Certificate in Editing from NYU School of Professional Studies, and a BA in Biological Sciences from Mount Holyoke College.